natgillin/translations-raw huggingface dataset:
I henhold til EF-traktatens artikel 194, stk. 1, fordeles antallet af medlemmer i ØSU mellem medlemsstaterne. I henhold til artikel 194, stk 2, beskikkes ØSU's medlemmer for fire år af Rådet ved enstemmig vedtagelse.
By letters addressed to the Secretary-General of the Council between 27 July 1994 and 23 September 1994, the Commission approved the various national lists.
Genbeskikkelse kan finde sted. Ifølge artikel 194, stk. 3, må ØSU's medlemmer ikke være bundet af nogen instruktion, og de udfører deres hverv i fuldkommen uafhængighed og i Fællesskabernes almene interesse.
At the time when the last letter, in which the Commission approved the French and Italian lists, was sent — 23 September 1994 — the Commission was accordingly aware of the composition of the ESC in its entirety, as envisaged by Coreper, and thus was in a position to make whatever comments it desired.
Første anbringende om en overtrædelse af traktatens artikel 195
Significantly, it simply communicated its approval.
Sagsøgerne har anført, at Rådet end ikke har forsøgt at foretage en selvstændig vurdering af de indstillede kandidaters repræsentativitet I stedet for at foretage et valg blandt de 48 navne, som Italien har indstillet, har Rådet blot uden drøftelse gentaget listen over primært indstillede kandidater, idet alle sekundært indstillede kandidater er blevet udelukket.
Lastly, it is appropriate to consider whether, as the applicants allege, Decision 94/660 fails to ensure adequate representation of producers.
Med henblik på beskikkelse af medlemmer af ØSU for perioden fra den 21. september 1994 til den 20. september 1998 fremsendte Rådets Generalsekretariat den 8. april 1994 en orienterende note til Gruppen vedrørende Almindelige Anliggender. I noten blev det bl.a. fremhævet, at det var vigtigt at kunne beskikke medlemmerne senest i begyndelsen af september 1994, således at arbejdet i ØSU's sektorer kunne fortsætte uden afbrydelse.
The Court finds that, in addition to the considerations set out in its preamble, Decision 94/660 lists the names of the persons appointed to the ESC by Member State and in each case indicates below each person's name the office or membership held, thus making it possible to determine the economic or social interests each is able to represent on the ESC.
I noten blev det ligeledes foreslået, at afgørelsen om beskikkelsen kunne træffes af Rådet i løbet af juli 1994, idet de nye medlemmers mandater dog først skulle gælde fra den 21. september 1994.
In the Court's view, Decision 94/660 thus justifies the choice of the members of the ESC by reference to the representativity requirements laid down in Articles 194 and 195 of the Treaty, and therefore contains an adequate statement of reasons.
Retten bemærker, at det påhviler Rådet ved efterprøvelsen af, at sammensætningen af ØSU på fællesskabsniveau sikrer de forskellige grupper inden for det økonomiske og sociale liv en passende repræsentation, selvstændigt at påse, at alle kandidaterne på de nationale lister er repræsentative, og det kan ikke anse sig for at være bundet af en af medlemsstaterne foretagen sondring mellem primært og sekundært indstillede kandidater.
The adequate representation required by Article 195(1) of the EC Treaty must be ensured at Community level and, having regard to the limited number of seats, it is not possible for all the components of each category of economic and social activity to be represented by nationals
Tre af de 84 italienske medlemmer er medlem af sagsøger 1 i denne sag.
The applicants are ordered jointly and severalty to pay the costs.»
indstillet primært, at Rådet ikke har foretaget en selvstændig vurdering af deres repræsentativitet.
Case T-391/94 Jean Baiwir ν Commission of the European Communities Staff case
I denne sammenhæng bemærkes, at den i artikel 195, stk. 1, omhandlede passende repræsentation skal sikres på fællesskabsniveau, og at det under hensyn til det begrænsede antal pladser er udelukket, at alle kategorier inden for det økonomiske og sociale liv kan være repræsenteret af statsborgere fra hver medlemsstat.
(Officials — Act adversely affecting an official — Time-limits prescribed by the Staff Regulations — Inadmissibility — Action for compensation) (Fourth Chamber)
Andet anbringende om en overtrædebe af traktatens artikel 190
(Competition — Application f or interim measures — Suspension of operation of a measure)
Kommissionen afgav i skrivelser til Rådets Generalsekretariat mellem den 27. juli og den 23. september 1994 positiv indstilling vedrørende de forskellige nationale lister.
The Bayer Group is an international chemical group which holds eighth position in the worldwide pharmaceutical industry.
Det bemærkes, at Kommissionen blot fremsendte sin positive indstilling uden bemærkninger.
According to the figures in the Commission Decision of 10 January 1996 relating to a proceeding under
Retten finder, at afgørelse 94/660 i denne affattelse i tilstrækkelig grad begrunder valget af medlemmerne af ØSU i forhold til kravene i traktatens artikel 194 og 195 om en passende repræsentation, og at afgørelse 94/660 således er tilstrækkeligt begrundet.
Article 85 of the EC Treaty (rV/34.279/F3: Adalat; hereinafter «the decision»), its sales for 1991-1992 amounted to approximately ECU 3 264 million.
Retten skal dernæst tage stilling til, om afgørelse 94/660, således som sagsøgerne hævder, ikke sikrer gruppen af producenter en passende repræsentation.
The parent company of the group, Bayer AG (hereinafter «Bayer» has for a number of years manufactured and marketed under the trade name Adalat (Adalate in
2) Sagsøgerne betaler in solidum, sagens omkostninger.'
France), a range of medicinal preparations (hereinafter «Adalat»), the principal ingredient of which is nifedipine, designed to treat cardiovascular illnesses.
Sag T-391/94 Jean Baiwir / Kommissionen for De Europæiske Fællesskaber Personalesag
Under Article 2 of the decision, Bayer is «required to terminate the infringement found in Article 1, and, in particular:
»Tjenestemænd — bebyrdende retsakt — frister i henhold til vedtægten — afvisning — erstatningssøgsmål· (Fjerde Afdeling)
According to information from the same source reproduced in the decision, Bayer holds around 7% and 9% respectively for coronary insufficiency and hypertension in Spain, 5% and 4% of the same markets in France, and 20% and 17% in the United Kingdom.
Sag T-41/96 R Bayer AG / Kommissionen for De Europæiske Fællesskaber Konkurrence
For Adelat Retard 20mg, the price difference in Spain was between 35% and 47% and, in France, around 24%.
»Konkurrence — særlige rettergangsformer — udsættelse af gennemførelsen·
Because of those price differences, wholesalers in Spain exported Adalat to the United Kingdom from 1989 onwards. French wholesalers followed suit as from 1991.
Faktiske forhold og retsforhandlinger respektive grossister i Spanien og Frankrig i forbindelse med deres vedvarende forretningsforhold har aftalt at forbyde eksport af Adelat til andre medlemsstater.
in order to «penalize» them by reductions in supplies.
Bayer-koncernen er en international kemisk koncern, som på verdensplan har ottendepladsen i lægemiddelbranchen.
wholesalers are concerned, in their adaptation to such conduct.
Koncernensmoderselskab, Bayer AG (»Bayer«), har i adskillige år under mærket »Adalat« (i Frankrig »Adalate«) produceret og forhandlet en række lægemidler (herefter samlet benævnt »Adalat«), hvis virksomme stof er nifedipin, som bruges til behandling af hjerte/kar-sygdomme.
The controversy concerns the question whether or not such conduct forms part of an agreement within the meaning of Article 85(1) of the Treaty and therefore falls within the scope of that article. The applicant argues that its refusals to supply were purely unilateral.
Ifølge beslutningens artikel 2 skal Bayer »bringe den i artikel 1 omhandlede overtrædelse til ophør og i forbindelse hermed især
The Commission argues that, on the contrary, they constitute one of the aspects of an agreement designed to wall off national markets.
Ifølge Bayer udgør Adalat's markedsandel i Fællesskabet ca. 8%. Ifølge samme kilde — gengivet i beslutningen — optager Bayer på markederne for midler mod hjerteinsufficiens og hypertension henholdsvis 7% og 9% i Spanien, henholdsvis 5% og 4% i Frankrig og henholdsvis 20% og 17% i Det Forenede Kongerige.
In this case, the facts do not demonstrate so clearly either that the system established by the applicant was intended to monitor the distribution of its products amongst its customers with the precise aim of imposing an export prohibition upon them, or that the wholesalers had given their tacit consent to such a prohibition in the context of their continuing business relations with Bayer Spain and Bayer France.
senest to måneder efter meddelelsen af nærværende beslutning fremsende en rundskrivelse til deres grossister i Frankrig og Spanien, hvori det klart anføres, at det er tilladt at eksportere inden for EF, og at sådan eksport ikke vil medføre nogen sanktioner senest to måneder efter meddelelsen af nærværende beslutning angive dette klart i de almindelige salgsbetingelser, der anvendes i Frankrig og Spanien«.
It follows from the above considerations as a whole, and without prejudice to the assessment to be made in the main proceedings, that the applicant's contention that there was no agreement containing an export prohibition between Bayer Spain and Bayer France and their respective wholesalers in those countries is not at first sight manifestly devoid of all foundation.
I de fleste medlemsstater fastsættes prisen på Adalat direkte eller indirekte af de nationale sundhedsmyndigheder. Fra 1989 til 1993 var de priser, som de spanske og franske sundhedsmyndigheder fastsatte, i gennemsnit 40% lavere end dem, der gjaldt i Det Forenede Kongerige.
Having regard to the arguments put forward by the parties, it should also be noted that, by applying Article 85(1) in certain circumstances to refusals to supply intended to restrain parallel exports, the Commission has adopted a decision likely to raise the particularly delicate question as to the circumstances in which a refusal to sell is capable, when it occurs in the context of continuing commercial relations, of constituting one of the aspects of an agreement containing an export prohibition.
For Adalat Retard 20 mg var prisforskellen i Spanien 35-47% og i Frankrig ca. 24%. Prisen på Adalat i kapselform var ligeledes i Spanien 48-55% lavere og i Frankrig 39-45% lavere end prisen i Det Forenede Kongerige.
Such a question, which concerns the determination of the factors constituting an agreement under Article 85, and hence the scope of that article itself, will require detailed examination in the main proceedings.
I beslutningens artikel 3 pålægges Bayer en bøde på 3 mio. ECU. I artikel 4 fastlægges en tvangsbøde på 1000 ECU for hver dags forsinkelse med opfyldelse af de i artikel 2 udtrykkeligt angivne forpligtelser.
At this interim stage, the applicant's arguments do not prima facie appear to be manifestly lacking in seriousness.
Ved stævning registreret på Rettens Justitskontor den 22. marts 1996 har Bayer nedlagt påstand om, at beslutningen annulleres.
On the question of urgency, the applicant has put forward a number of arguments to establish that the damage it risks suffering in the event of immediate implementation of the provision in question would be serious, difficult to repair, or at the very least disproportionate, having regard in particular to the balancing of the interests involved.
På grund af disse prisforskelle påbegyndte spanske grossister i 1989 en eksport af Adalat til Det Forenede Kongerige.
The applicant recognizes that the refusals to supply in question were intended to stem parallel exports by limiting quantities supplied.
Fra 1991 har franske grossister fulgt samme fremgangsmåde. Ifølge Bayer er Bayer UK's salg af Adalat i perioden fra 1989 til 1993 næsten halveret på grund af parallelimporter.
However, it argues that the information system which it applied was designed only to identify the wholesalers whose orders had increased out of proportion in relation to previous years.
Bayer's britiske datterselskab har således lidt et omsætningstab på 230 mio. DM, hvilket for Bayer har udgjort et indtægtstab på 100 mio. DM.
Such conduct — if established — does not necessarily have be interpreted, in itself, as intended to impose an export prohibition on wholesalers.
Ved særskilt dokument registreret på Rettens Justitskontor den 22. marts 1996 har sagsøgeren tillige begæret gennemførelsen af beslutningens artikel 2 udsat
The applicant was entitled in principle to organize its distribution system as it chose and to make full use of its contractual freedom in putting its commercial policy into effect, without being bound by an obligation under Article 85(1) to supply its customers.
Stillet ansigt til ansigt hermed besluttede Bayer Spanien og Bayer Frankrig ikke længere at imødekomme alle ordrer fra grossister i Spanien og Frankrig.
In those circumstances, the Court must examine the applicant's objections to the Commission's argument that the «distribution monitoring system» established by the applicant was designed to detect exporting wholesalers precisely
Det bemærkes, at parterne er fundamentalt uenige om, hvorledes den adfærd, som i beslutningen anses for at være en overtrædelse, og som består i, at sagsøgeren efter bestemte kriterier har reduceret sine leverancer med
In assessing the seriousness of the damage claimed by the applicant, particular account must be taken of the fact that Article 2 of the decision is capable of being interpreted, in the light of the grounds stated for that decision, as prohibiting supply refusals aimed at preventing the growth of parallel exports of Adalat to the United Kingdom by the use of a monitoring system which, in the applicant's submission, is not designed to pressurize wholesalers into not exporting.
Kommissionen traf herefter over for Bayer beslutningen af 10. januar 1996 om en procedure i henhold til EF-traktatens artikel 85 (»beslutningen«), som i artikel 1 fastslår, at Bayer AG har overtrådt traktatens artikel 85, idet Bayer Spanien og Bayer Frankrig med deres
It is clearly established in the caselaw that, whilst a refusal to sell may in certain closely defined circumstances form part of an agreement within the meaning of Article 85(1), freedom of contract must nevertheless remain the general rule in this area, as the Court of First Instance pointed out in Case T-24/90 Automec ν Commission [1992] ECR 11-2223, at paragraphs 51 and 52 of its judgment. In this case, if the applicant's
henblik på at »straffe« dem ved at indskrænke leverancerne.
argument were to be accepted by the Court as well-founded, immediate implementation of the provision in question would risk depriving the applicant of its independence in defining certain crucial elements in its business policy.
Uenigheden vedrører spørgsmålet om, hvorvidt disse former for adfærd er en del af en aftale i traktatens artikel 85, stk. l's betydning og således falder inden for denne bestemmelses anvendelsesområde.
losses of profit for the United Kingdom subsidiary but also the risk that the pharmaceutical branch of that subsidiary might be deprived of its economic basis, resulting in the dismissal of many employees.
Ifølge sagsøgeren er leveringsnægtelserne helt ensidige.
It is undisputed that Adalat represents 56% of the total turnover of Bayer UK
I det foreliggende tilfælde fremgår det hverken klart og åbenbart, at det af sagsøgeren gennemførte system havde til formål at kontrollere sagsøgerens kunders varedistribution netop med det formål at pålægge dem et eksportforbud, eller at grossisterne stiltiende havde samtykket i et sådant forbud som et led i deres vedvarende forretningsforhold med Bayer Spanien og Bayer Frankrig.
A situation of that kind is particularly likely to cause serious damage to the applicant in the context of the pharmaceutical industry, which is distinctive in that prices and methods of reimbursement are fixed or controlled by national health services, thereby giving rise to large disparities in the prices for a single medicine in the various Member States.
Det følger heraf, at sagsøgerens argumentation, hvorefter der ikke foreligger nogen aftale om eksportforbud mellem Bayer Spanien og Bayer Frankrig og deres respektive grossister i de to lande, ikke umiddelbart savner ethvert grundlag, idet dog den vurdering, som skal finde sted som et led i hovedsagen, ikke herved er foregrebet.
In this case, it is undisputed that the applicant has no control over its prices in the exporting countries, Spain and France, where the prices of Adalat products are fixed by the competent authorities at a level which is currently, on average, around 40% lower than prices charged in the United Kingdom.
Når henses til parternes anbringender, må det indledningsvis fremhæves, at Kommissionen — ved under visse betingelser at anvende artikel 85, stk. 1, på leveringsnægtelser, som har til formål at begrænse paralleleksport — har truffet en beslutning, som rejser det særligt vanskelige spørgsmål, under hvilke omstændigheder en leveringsnægtelse, når den er et led i vedvarende forretningsforhold, kan være en del af en aftale om eksportforbud.
In those circumstances, the risk of a significant increase in parallel imports of Adalat to the United Kingdom, if the provision in question were given immediate effect, cannot be ruled out.
De af sagsøgeren fremførte anbringender forekommer på sagens nuværende stadium umiddelbart ikke at være uden enhver form for seriøst grundlag.
It is therefore necessary to undertake a balancing of the interests involved, in order to determine whether the condition regarding urgency is satisfied.
Sagsøgeren erkender, at de omhandlede leveringsnægtelser har til formål at dæmme op for paralleleksport ved at begrænse leverancerne.
The risk faced by the applicant must be balanced against first, the interest of wholesalers in Spain and France in increasing the volume of their exports to the United Kingdom in the context of a unified market and, secondly, the interest of the NHS and of United Kingdom consumers and taxpayers in a reduction of Adalat prices on the national market.
Imidlertid skulle det anvendte informationssystem alene indkredse hvilke grossister, som havde afgivet uforholdsmæssigt store ordrer i forhold til året før.
Comparison of the various interests involved shows that the damage likely to be caused to the applicant by immediate implementation of the provision in question would be disproportionate in relation to the interests of wholesalers in Spain and France in increasing their exports.
En sådan adfærd — hvis den var klarlagt — bør ikke nødvendigvis i sig selv fortolkes som et forsøg på at forbyde eksport til grossisterne.
The latter already operate in national markets which are far from being entirely walled off by the disputed business policy of the applicant, as is demonstrated by the level of parallel imports of Adalat to the United Kingdom.
Sagsøgeren var principielt berettiget til frit at organisere sit distributionsnet og udnytte sin kontraktfrihed fuldt ud i sin forretningspolitik uden i medfør af artikel 85, stk. 1, at være bundet af en pligt til at levere til sine kunder.
Provisional maintenance of the current situation, pending the Court's ruling on the main application, cannot therefore be regarded as an intolerable hindrance to the integration of the market and the free operation of competition.
Der må herefter tages stilling til sagsøgerens indvendinger mod Kommissionens anbringende, hvorefter sagsøgerens »distributionskontrolsystem« havde til formål at opspore de eksporterende grossister netop med
As for the interest of the NHS and, in the final analysis, of United Kingdom consumers and taxpayers, it should be remembered that the prices currently charged by Bayer UK, which are higher than those fixed by the Spanish and French authorities, are in any case subject to indirect control in the United Kingdom by the competent authorities.
Selv om en leveringsnægtelse efter fast retspraksis under visse klart afgrænsede særlige omstændigheder kan indgå som et led i en aftale i den i artikel 85, stk. 1, anførte betydning, er kontraktfriheden dog på dette område stadig hovedreglen, jf. Rettens dom af 18. september 1992, Automec mod Kommissionen.
In this case, the applicant has an interest in the requested suspension in order to preserve its freedom of contract (see paragraphs 43 and 54 above) and to maintain the status quo.
Såfremt Retten i den foreliggende sag tog sagsøgerens anbringende til følge, ville der være risiko for, at den omhandlede bestemmelses omgående ikrafttræden ville berøve den pågældende
On that latter aspect, the constraint in which the applicant might find itself to lower Adalat prices in the United Kingdom, in order to prevent a significant increase in parallel imports, entails not only the risk of major and irrecoverable
vil kunne fratage dette datterselskabs lægemiddelafdeling sit økonomiske grundlag og medføre afskedigelse af adskillige lønmodtagere.
Case C-313/94 Fratelli Graffione ν Fransa restriction within the meaning of Article 30 of the Treaty and cannot be justified on grounds of fair trading.»
En sådan situation ville imidlertid nemt kunne forårsage et alvorligt tab for sagsøgeren inden for lægemiddelbranchen, som er karakteriseret ved, at de nationale sundhedsmyndigheder fastsætter eller kontrollerer priserne og refusionsordningerne, hvilket medfører store forskelle i de priser, som gælder for samme lægemiddel i forskellige medlemsstater.
Preliminary ruling — Tribunale di Chiavari — Interpretation of Articles 30 and 36 of the EC Treaty and Article 12(2) (b) of the First Council Directive 89/104/EEC to approximate the laws of the Member States relating to trade marks — Lawful marketing of a product covered by a trade mark in a Member State — Prohibition on importation into another Member State — Toilet paper marketed under the trade name «Cotonelle»
Under disse omstændigheder kan det ikke udelukkes, at der er risiko for en mærkbar stigning i parallelimport af Adalat til Det Forenede Kongerige, såfremt den omhandlede bestemmelse træder omgående i kraft.
Joined Cases C-267/95 and C-268/95 Merck & Co. Inc. and Others ν Primecrown Ltd and Others Beecham Group pic ν Europharm of Worthing Ltd Advocate General F.G. Jacobs delivered his Opinion at the sitting of the Full Court on 6 June 1996.
Den risiko, som sagsøgeren løber, skal afvejes såvel i forhold til den interesse, som grossister i Spanien og Frankrig har i at kunne øge deres eksport til Det Forenede Kongerige inden for rammerne af det fælles marked, som i forhold til den interesse, National Health Service (»NHS«), forbrugerne og skatteborgerne i Det Forenede Kongerige har i, at prisen på Adalat sænkes på det nationale marked. Når man sammenholder de forskellige involverede interesser fremgår det, at det tab, som sagsøgeren muligvis ville lide, såfremt den omhandlede bestemmelse træder i kraft omgående, ikke står i rimeligt forhold til den interesse, som grossister i Spanien og i Frankrig har i at kunne forøge deres eksport.
Preliminary ruling—High Court of Justice (Queen's Bench Division) — Interpretation of Articles 47 and 209 of the Act of Accession of 1985 - Date on which those articles ceased to apply to pharmaceutical products imported from Spain or Portugal or marketed in those countries — Interpretation of Articles 30 and 36 of the EC Treaty — Right of the owner of a patent registered in a Member State to oppose the importation by a third party of the same product from a country where it had been put on the market for the first time after accession to the Communities but at a time when a product patent could not be obtained — Conditions